Hatch requests review of data hub security for insurance exchanges

Utah's Sen. Orrin Hatch, ranking Republican on the Senate Finance Committee, has asked the Government Accountability Office to review security and privacy features of the data hub for the new health insurance exchanges, The Hill's Healthwatch reported.

In a letter to the GAO, Hatch asked for information on the "security and privacy of the data being exchanged" through the hub, which will connect state health insurance exchanges with federal agencies to determine if an exchange applicant is eligible for subsidies.

Hatch also asked the GAO to explain how federal agencies are planning to manage risk and to determine the effectiveness of plans to correct any problems, according to Healthwatch.

Hatch's request followed revelations earlier this month from the Department of Health & Human Services Inspector General, which reported that security testing for the data hub is behind schedule. After twice being delayed, a security control assessment initially scheduled for early June was to take place in mid-August, the IG said.

The Centers for Medicare & Medicaid Services (CMS) "is working with very tight deadlines to ensure that security measures for the Hub are assessed, tested, and implemented by the expected initial open enrollment date of Oct. 1, 2013," the report's authors said.

"If there are additional delays in completing the security assessment and testing, the CMS CIO may have limited information on the security risks and controls when granting the security authorization of the Hub."

For more information:
- read the Healthwatch article
- here's the HHS IG report (.pdf)

Suggested Articles

Insurance company Oscar hired former Uber talent as its chief executive officer, Jonathan Bush gets a new gig at Firefly Health and more.

Fourteen doctors and other medical professionals were among those charged in fraud cases that totaled $258 million in California, Oregon, and Arizona.

House Speaker Nancy Pelosi released a plan to give Medicare the power to negotiate for lower drug prices, but will it get out of Congress?